Renal Failure
Conditions
Keywords
renal failure, cardiopulmonary bypass
Brief summary
This project evaluates whether nesiritide, human recombinant brain natriuretic peptide, confers renal protection during cardiovascular surgery by attenuating the inflammatory response.
Detailed description
This will be a randomized, prospective blinded pilot study comparing nesiritide to placebo in patients undergoing aortic arch, ascending aorta, aortic valve or mitral valve surgery with baseline GFR 30-90ml/min. Patients were randomized to either placebo or nesiritide (administered prophylactically starting in the operating room prior to incision at 0.01 mcg/kg /minute with no bolus and continued for 48 hours).
Interventions
infuses at 0.01MCG/KG/min for 48 hours
infuses at 0.01MCG/KG/min for 48 hours
Sponsors
Study design
Eligibility
Inclusion criteria
* Patients undergoing surgery on their aortic arch, ascending aorta, or having aortic valve or mitral valve surgery * Baseline MDRD (modification of diet in renal disease) calculated GFR (Glomerular Filtration Rate) 30-90 ml/min. * Signed Informed Consent
Exclusion criteria
* Age \<18 or \>80 * Ejection Fraction \<30%. * Presence of endocarditis or other infection. * Presence or anticipated use of an intra-aortic balloon pump. * History of an organ transplant. * History of an adverse reaction to nesiritide. * Surgery performed without cardiopulmonary bypass. * Receiving Aprotinin * Dopamine administered in doses \<5 mcg /kg min. * Women of child bearing potential or pregnant or breastfeeding. * Participation in any other investigational trial * Jehovah Witness * Bleeding Disorder * Active Endocarditis
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Measure Neutrophils to Measure Kidney Injury | 30 days from the start of infusion | 0.35 mL of whole blood from each patient was applied to a microfluidics chip to isolate neutrophils. Total RNA was subsequently isolated and gene expression (for all genes listed below) was measured with an Affymetrix gene chip. Data was normalized using RMA (Robust multi-array average) and expressed as log2 expression. |
| The Examine and Measure Cytokines to Measure Kidney Injury | 30 days from the start of infusion | Serial measurement of serum cytokine profiles were measured with multiplex Luminex plates that enable the simultaneous measurement of 23 cytokines. |
| The Examine and Measure Endothelin-1 to Measure Kidney Injury | 30 days from the start of infusion | Serial measurements of Endothelin-1 levels were measured to determine if natriuretic peptides exert their renal protective effects by preserving renal afferent arteriole flow by antagonizing the vasoconstrictive effects of Endothelin-1. |
| The Examine and Measure Urinary NGAL to Measure Kidney Injury | A change in urinary NGAL 2 hours after bypass was stopped and 5 minutes after the start of spontaneous circulation was resumed. | Urinary NGAL,a biomarker for kidney injury was measured. |
Countries
United States
Participant flow
Recruitment details
Starting in June 2010 and ending in December 2012, subjects were seen in outpatient clinics or in the hospital. The pre-operative labs were used to screen and enroll subjects.
Pre-assignment details
Out of the 37 signed informed consent there were 8 subjects who were consented and did not participate: 2 subjects changed their mind, 5 subjects creatinine level was not within the protocol level for participation, 1 subject surgery was canceled. This left 29 subjects to participate in the study.
Participants by arm
| Arm | Count |
|---|---|
| Nesiritide infuses at 0.01 MCG (micrograms)/KG (kilograms)/min (minute) for 48 hours
Nesiritide: infuses at 0.01MCG/KG/min for 48 hours | 14 |
| Placebo infuses at 0.01MCG/KG/min for 48 hours
Placebo: infuses at 0.01MCG/KG/min for 48 hours | 15 |
| Total | 29 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 |
|---|---|---|---|
| Overall Study | Death | 0 | 1 |
Baseline characteristics
| Characteristic | Nesiritide | Placebo | Total |
|---|---|---|---|
| Age, Categorical <=18 years | 0 Participants | 0 Participants | 0 Participants |
| Age, Categorical >=65 years | 10 Participants | 6 Participants | 16 Participants |
| Age, Categorical Between 18 and 65 years | 4 Participants | 9 Participants | 13 Participants |
| Region of Enrollment United States | 14 participants | 15 participants | 29 participants |
| Sex: Female, Male Female | 5 Participants | 5 Participants | 10 Participants |
| Sex: Female, Male Male | 9 Participants | 10 Participants | 19 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | — / — | — / — |
| other Total, other adverse events | 2 / 14 | 1 / 15 |
| serious Total, serious adverse events | 0 / 14 | 3 / 15 |
Outcome results
Measure Neutrophils to Measure Kidney Injury
0.35 mL of whole blood from each patient was applied to a microfluidics chip to isolate neutrophils. Total RNA was subsequently isolated and gene expression (for all genes listed below) was measured with an Affymetrix gene chip. Data was normalized using RMA (Robust multi-array average) and expressed as log2 expression.
Time frame: 30 days from the start of infusion
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: PRSS3 | 6.338 log2 expression | Standard Deviation 0.123 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: IL23A | 4.508 log2 expression | Standard Deviation 0.177 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: C6orf145 | 5.501 log2 expression | Standard Deviation 0.216 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: HIST1H1C | 8.888 log2 expression | Standard Deviation 0.506 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: TBC1D26 /// ZNF286A | 4.990 log2 expression | Standard Deviation 0.092 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: RPL27 | 9.269 log2 expression | Standard Deviation 0.191 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: LOC440087 | 3.553 log2 expression | Standard Deviation 0.181 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: OXT | 6.899 log2 expression | Standard Deviation 0.175 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: GIPC3 | 6.158 log2 expression | Standard Deviation 0.124 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: FAM98C | 6.778 log2 expression | Standard Deviation 0.146 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: PTOV1 | 8.234 log2 expression | Standard Deviation 0.21 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: RPS16 | 9.077 log2 expression | Standard Deviation 0.195 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: ERCC1 | 5.798 log2 expression | Standard Deviation 0.171 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: LOC339344 | 7.522 log2 expression | Standard Deviation 0.238 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: ATG10 | 5.347 log2 expression | Standard Deviation 0.39 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: SLC35C1 | 6.422 log2 expression | Standard Deviation 0.155 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: PTPMT1 /// NDUFS3 /// PTPMT1 | 6.702 log2 expression | Standard Deviation 0.168 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: SIDT2 | 6.792 log2 expression | Standard Deviation 0.215 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: Q6ZVY8_HUMAN | 5.229 log2 expression | Standard Deviation 0.124 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: CECR5 | 5.519 log2 expression | Standard Deviation 0.108 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: VPS35 | 9.042 log2 expression | Standard Deviation 0.339 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: LGALS2 | 5.513 log2 expression | Standard Deviation 0.174 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: NDUFA6 | 6.496 log2 expression | Standard Deviation 0.334 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: LOC497190 /// NP_001011880.1 | 6.469 log2 expression | Standard Deviation 0.089 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: CXorf52 | 6.151 log2 expression | Standard Deviation 0.48 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: MAP4K4 | 10.656 log2 expression | Standard Deviation 0.121 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: LOC441241 /// VKORC1L1 | 6.418 log2 expression | Standard Deviation 0.349 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: DBF4 | 4.706 log2 expression | Standard Deviation 0.245 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: SP100 | 9.074 log2 expression | Standard Deviation 0.242 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: TPT1 | 9.177 log2 expression | Standard Deviation 0.139 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: LOC285908 | 7.517 log2 expression | Standard Deviation 0.173 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: LOXHD1 | 6.886 log2 expression | Standard Deviation 0.336 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: DYM | 8.158 log2 expression | Standard Deviation 0.241 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: Q6ZU44_HUMAN | 4.953 log2 expression | Standard Deviation 0.2 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: BAZ2B | 8.802 log2 expression | Standard Deviation 0.33 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: GRM8 | 4.303 log2 expression | Standard Deviation 0.114 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: Q6ZP42_HUMAN | 4.967 log2 expression | Standard Deviation 0.251 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: HTR2B | 4.337 log2 expression | Standard Deviation 0.263 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: TUFT1 | 5.453 log2 expression | Standard Deviation 0.251 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: LOC728449 /// ANXA8L2 | 5.755 log2 expression | Standard Deviation 0.105 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: RPS24 | 7.029 log2 expression | Standard Deviation 0.153 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: DOLPP1 | 5.707 log2 expression | Standard Deviation 0.218 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: UBQLN1 | 9.129 log2 expression | Standard Deviation 0.174 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: TNFSF15 | 5.080 log2 expression | Standard Deviation 0.296 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: Q5QFB9_HUMAN | 4.770 log2 expression | Standard Deviation 0.456 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: CYP19A1 | 3.696 log2 expression | Standard Deviation 0.126 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: Q6UWF5_HUMAN | 3.851 log2 expression | Standard Deviation 0.309 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: LOC340204 /// NP_001010886.1 | 4.453 log2 expression | Standard Deviation 0.208 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: CCDC76 | 3.702 log2 expression | Standard Deviation 0.211 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: PRAMEF8 | 5.828 log2 expression | Standard Deviation 0.232 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: RPL26 | 7.440 log2 expression | Standard Deviation 0.205 |
| Nesiritide | Measure Neutrophils to Measure Kidney Injury | Gene: ZNF540 | 4.284 log2 expression | Standard Deviation 0.11 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: MAP4K4 | 10.651 log2 expression | Standard Deviation 0.159 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: TUFT1 | 5.630 log2 expression | Standard Deviation 0.195 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: PRSS3 | 6.241 log2 expression | Standard Deviation 0.118 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: IL23A | 4.546 log2 expression | Standard Deviation 0.301 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: LOC441241 /// VKORC1L1 | 6.533 log2 expression | Standard Deviation 0.453 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: C6orf145 | 5.444 log2 expression | Standard Deviation 0.156 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: PRAMEF8 | 5.856 log2 expression | Standard Deviation 0.233 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: HIST1H1C | 9.404 log2 expression | Standard Deviation 0.903 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: DBF4 | 4.776 log2 expression | Standard Deviation 0.364 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: TBC1D26 /// ZNF286A | 4.930 log2 expression | Standard Deviation 0.113 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: LOC728449 /// ANXA8L2 | 5.801 log2 expression | Standard Deviation 0.195 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: RPL27 | 9.315 log2 expression | Standard Deviation 0.214 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: SP100 | 9.205 log2 expression | Standard Deviation 0.191 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: LOC440087 | 3.647 log2 expression | Standard Deviation 0.218 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: CYP19A1 | 3.725 log2 expression | Standard Deviation 0.131 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: OXT | 6.884 log2 expression | Standard Deviation 0.102 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: TPT1 | 9.242 log2 expression | Standard Deviation 0.125 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: GIPC3 | 6.097 log2 expression | Standard Deviation 0.114 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: ZNF540 | 4.255 log2 expression | Standard Deviation 0.12 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: RPS24 | 7.063 log2 expression | Standard Deviation 0.153 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: FAM98C | 6.857 log2 expression | Standard Deviation 0.129 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: LOC285908 | 7.454 log2 expression | Standard Deviation 0.322 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: PTOV1 | 8.153 log2 expression | Standard Deviation 0.149 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: CCDC76 | 3.627 log2 expression | Standard Deviation 0.211 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: RPS16 | 9.012 log2 expression | Standard Deviation 0.221 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: LOXHD1 | 6.742 log2 expression | Standard Deviation 0.398 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: ERCC1 | 5.843 log2 expression | Standard Deviation 0.242 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: DOLPP1 | 5.759 log2 expression | Standard Deviation 0.2 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: LOC339344 | 7.502 log2 expression | Standard Deviation 0.164 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: DYM | 8.088 log2 expression | Standard Deviation 0.281 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: ATG10 | 5.286 log2 expression | Standard Deviation 0.308 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: Q6UWF5_HUMAN | 3.893 log2 expression | Standard Deviation 0.209 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: SLC35C1 | 6.358 log2 expression | Standard Deviation 0.188 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: Q6ZU44_HUMAN | 4.751 log2 expression | Standard Deviation 0.159 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: PTPMT1 /// NDUFS3 /// PTPMT1 | 6.706 log2 expression | Standard Deviation 0.177 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: UBQLN1 | 9.172 log2 expression | Standard Deviation 0.214 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: SIDT2 | 6.870 log2 expression | Standard Deviation 0.161 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: BAZ2B | 8.811 log2 expression | Standard Deviation 0.117 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: Q6ZVY8_HUMAN | 5.132 log2 expression | Standard Deviation 0.214 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: RPL26 | 7.481 log2 expression | Standard Deviation 0.212 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: CECR5 | 5.499 log2 expression | Standard Deviation 0.105 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: GRM8 | 4.259 log2 expression | Standard Deviation 0.142 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: VPS35 | 8.974 log2 expression | Standard Deviation 0.379 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: TNFSF15 | 5.072 log2 expression | Standard Deviation 0.33 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: LGALS2 | 5.565 log2 expression | Standard Deviation 0.187 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: Q6ZP42_HUMAN | 5.040 log2 expression | Standard Deviation 0.336 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: NDUFA6 | 6.680 log2 expression | Standard Deviation 0.455 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: LOC340204 /// NP_001010886.1 | 4.437 log2 expression | Standard Deviation 0.273 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: LOC497190 /// NP_001011880.1 | 6.470 log2 expression | Standard Deviation 0.116 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: HTR2B | 4.037 log2 expression | Standard Deviation 0.289 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: CXorf52 | 6.301 log2 expression | Standard Deviation 0.387 |
| Placebo | Measure Neutrophils to Measure Kidney Injury | Gene: Q5QFB9_HUMAN | 4.430 log2 expression | Standard Deviation 0.427 |
The Examine and Measure Cytokines to Measure Kidney Injury
Serial measurement of serum cytokine profiles were measured with multiplex Luminex plates that enable the simultaneous measurement of 23 cytokines.
Time frame: 30 days from the start of infusion
Population: randomized per protocol
| Arm | Measure | Group | Value (MEDIAN) |
|---|---|---|---|
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | G-CSF 1 hour post bypass | 124.298 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-6 time point 0 | 28.167 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-6 1 hour post bypass | 33.457 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-6 2 hour post bypass | 44.383 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-6 4hour post bypass | 35.759 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-6 6 hour post bypass | 28.593 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-6 8 hours post bypass | 29.794 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-6 24 hours post bypas | 29.513 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL8 baseline | 5.377 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL8- 1 hour post bypass | 17.107 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL8-2 hour post bypass | 17.068 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL8 4 hour post bypass | 16.005 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL8 6 hour post bypass | 14.290 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL8 8hour post bypass | 14.550 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL8 24 hour post bypass | 12.264 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL10 baseline | 8.063 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL10 0 time point | 1289.776 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL 10 1 hour post bypass | 1558.903 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL10 2 hour post bypass | 667.765 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL 10 4 hour post bypass | 309.351 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL 10 6 hour post bypass | 107.778 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL 10 8 hour post bypass | 103.791 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL 10 24 hour post bypass | 18.597 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | TNF alpha baseline | 6.286 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | TNF alpha 0 time point | 8.253 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | TNF alpha 1hour post bypass | 10.729 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | TNF alpha 2 hour post bypass | 9.855 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | TNF alpha 4 hour post bypass | 8.843 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | TNF alpha 6 hour post bypass | 7.185 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | TNF alpha 8 hour post bypass | 5.175 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | TNF alpha 24 hour post bypass | 4.620 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | TNF beta baseline | 1.162 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | TNF beta 0 time point | 1.110 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | TNF beta 4 hour post bypass | 1.698 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | TNF beta 1 hour post bypass | 0.898 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | TNF beta 2 hour post bypass | 1.302 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | TNF beta 6 hour post bypass | 1.234 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | TNF beta 8 hour post bypass | 1.389 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | TNF beta 24 hour post bypass | 0.309 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | VEGF baseline | 102.054 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | VEGF 0 time point | 70.647 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | VEGF 1 hour post bypass | 89.814 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | VEGF 2 hour post bypass | 91.881 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | VEGF 6 hour post bypass | 83.581 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | VEGF 8 hour post bypass | 84.494 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | VEGF 24 hour post bypass | 76.771 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | MCP-1 baseline | 174.848 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | MCP-1 0 timepoint | 478.742 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | MCP-1 1 hour post bypass | 483.095 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | MCP-1 2 hour post bypass | 441.203 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | MCP-1 4 hour post bypass | 265.736 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | MCP-1 6 hour post bypass | 191.735 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | MCP-1 8 hour post bypass | 180.749 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | MCP-1 24 hour post bypass | 202.621 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | EGF baseline | 47.564 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | EGF 0 timepoint | 31.242 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | EGF 1 hour post bypass | 35.745 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | EGF 2 hour post bypass | 24.052 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | EGF 4 hour post bypass | 29.841 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | EGF 6 hour post bypass | 33.050 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | EGF 8 post bypass | 27.022 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | EGF 24 hour post bypass | 30.494 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1 alpha baseline | 12.372 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1 alpha 0 time | 41.216 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1 alpha 1 hour post bypass | 26.101 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1 alpha 2 hour post bypass | 22.122 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1 alpha 4 hour post bypass | 18.137 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1 alpha 6 hour post bypass | 15.148 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1 alpha 8 hour post bypass | 9.334 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1 alpha 24 hour post bypass | 2.974 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1Beta baseline | 1.014 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1Beta 0 time point | 0.775 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1Beta 1 hour post bypass | 0.653 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1Beta 2 hour post bypass | 1.311 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1Beta 4 hour post bypass | 1.716 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1Beta 6 hour post bypass | 1.119 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1Beta 8 hour post bypass | 0.875 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1Beta 24 hour post bypass | 0.000 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1RA baseline | 26.419 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1RA 0 time point | 41.945 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1RA 1 hour post bypass | 68.792 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1RA 2 hour post bypass | 98.089 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1RA 4 hour post bypass | 105.861 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1RA 6 hour post bypass | 67.705 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1RA 8 hour post bypass | 45.097 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1RA 24 hour post bypass | 21.181 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-2 baseline | 0.850 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-2 0 timepoint | 1.130 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-2 1 hour post bypass | 1.714 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-2 2 hour post bypass | 1.714 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-2 4 hour post bypass | 1.753 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-2 6 hour post bypass | 1.297 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-2 8 hour post bypass | 1.281 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-2 24 hour post bypass | 0.921 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-3 baseline | 0.093 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-3 0 timepoint | 0.185 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-3 1 hour post bypass | 0.000 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-3 2 hour post bypass | 0.000 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-3 4 hour post bypass | 0.000 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL_3 6 hour post bypass | 0.061 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-3 8 hour post bypass | 0.061 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL_3 24 hour post bypass | 0.073 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-4 baseline | 4.295 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-4 0 timepoint | 6.285 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-4 1 hour post bypass | 6.221 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL_4 2 hour post bypass | 5.534 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | MIP-1 beta 8 hour post bypass | 22.676 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | MIP-1 beta 24 hour post bypass | 18.726 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | G-CSF baseline | 50.953 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | G-CSF 0 time point | 92.559 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | G-CSF 2 hour post bypass | 249.816 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | G-CSF 4 hour post bypass | 285.277 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | G-CSF 6 hour post bypass | 252.546 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | G-CSF 8 hour post bypass | 264.061 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | G-CSF 24 hour post bypass | 309.690 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-4 4 hour post bypass | 6.743 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-4 6 hour post bypass | 4.859 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-4 8 hour post bypass | 4.063 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL_4 24 hour post bypass | 3.634 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-5 baseline | 0.563 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-5 0 timepoint | 0.134 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-5 1 hour post bypass | 0.169 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-5 2 hour post bypass | 0.291 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-5 4 hour post bypass | 0.626 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-5 6 hour post bypass | 0.334 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-5 8 hour post bypass | 0.387 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-5 24 hour post bypass | 0.373 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-7 baseline | 4.032 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-7 0 timepoint | 3.673 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-7 1 hour post bypass | 2.973 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-7 2 hour post bypass | 2.469 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-7 4 hour post bypass | 3.061 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-7 6 hour post bypass | 3.391 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-7 8 hour post bypass | 3.506 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-7 24 hour post bypass | 3.656 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-13 baseline | 0.922 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-13 0 timepoint | 0.133 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-13 4 hour post bypass | 1.571 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-13 6 hour post bypass | 1.138 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-13 8 hour post bypass | 0.786 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-13 24 hour post bypass | 0.094 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-15 baseline | 1.905 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-15 0 timepoint | 3.200 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-15 1 hour post bypass | 4.228 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-15 2 hour post bypass | 5.556 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-15 4 hour post bypass | 5.723 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-15 6 hour post bypass | 5.021 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-15 8 hour post bypass | 4.984 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-15 24 hour post bypass | 6.120 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-17 baseline | 1.171 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-17 0 time point | 0.765 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-17 1 hour post bypass | 2.174 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-17 2 hour post bypass | 1.381 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-17 4 hour post bypass | 1.682 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-17 6 hour post bypass | 0.815 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL- 17 8 hour post bypass | 0.817 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-17 24 hour post bypass | 0.397 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IP-10 baseline | 506.657 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IP-10 0 time point | 2340.935 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IP-10 1 hour post bypass | 1828.152 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IP-10 2 hour post bypass | 1571.877 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IP-10 4 hour post bypass | 1072.023 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IP-10 6 hour post bypass | 704.208 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IP-10 8 hour post bypass | 448.938 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IP-10 24 hour post bypass | 243.332 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | MIP-1 alpha baseline | 2.251 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | MIP-1 alpha 0 time point | 8.880 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | MIP-1 alpha 1 hour post bypass | 9.042 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | MIP-1 alpha 2 hour post bypass | 6.610 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | MIP-1 alpha 4 hour post bypass | 4.024 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | MIP-1 alpha 6 hour post bypass | 3.017 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | MIP-1 alpha 8 hour post bypass | 1.933 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | MIP-1 alpha 24 hour post bypass | 1.279 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | MIP-1 beta baseline | 22.626 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | MIP-1 beta 1 hour post bypass | 85.082 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | MIP-1 beta 2 hour post bypass | 53.750 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | MIP-1 beta 4 hour post bypass | 34.010 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-8 0 time point | 16.821 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | VEGF 4 hour poswt bypass | 88.005 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-13 1 hour post bypass | 0.719 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-13 2 hour post bypass | 2.352 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | MIP-1 beta 0 time point | 55.229 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | MIP-1 beta 6 hour post bypass | 26.524 pg/ml |
| Nesiritide | The Examine and Measure Cytokines to Measure Kidney Injury | IL-6 baseline | 1.750 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-13 6 hour post bypass | 0.000 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-6 baseline | 1.959 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-2 8 hour post bypass | 0.599 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-6 time point 0 | 63.930 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-13 1 hour post bypass | 0.000 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-6 1 hour post bypass | 57.412 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-2 24 hour post bypass | 0.172 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-6 2 hour post bypass | 43.523 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-13 8 hour post bypass | 0.000 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-6 4hour post bypass | 37.967 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-3 baseline | 0.000 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-6 6 hour post bypass | 27.840 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IP-10 6 hour post bypass | 575.429 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-6 8 hours post bypass | 21.673 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-3 0 timepoint | 0.000 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-6 24 hours post bypas | 34.650 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-13 24 hour post bypass | 0.000 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL8 baseline | 5.238 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-3 1 hour post bypass | 0.000 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL8- 1 hour post bypass | 20.873 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | MIP-1 beta 1 hour post bypass | 57.405 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL8-2 hour post bypass | 23.607 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-3 2 hour post bypass | 0.000 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL8 4 hour post bypass | 17.627 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-15 baseline | 0.969 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL8 6 hour post bypass | 19.880 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-3 4 hour post bypass | 0.000 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL8 8hour post bypass | 16.282 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IP-10 8 hour post bypass | 449.376 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL8 24 hour post bypass | 14.600 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL_3 6 hour post bypass | 0.000 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL10 baseline | 9.130 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-15 0 timepoint | 3.093 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL10 0 time point | 2206.177 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-3 8 hour post bypass | 0.000 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL 10 1 hour post bypass | 2074.906 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | G-CSF 0 time point | 150.567 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL10 2 hour post bypass | 844.352 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL_3 24 hour post bypass | 0.000 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL 10 4 hour post bypass | 230.101 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL 10 6 hour post bypass | 95.925 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-15 1 hour post bypass | 3.981 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-4 baseline | 0.166 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL 10 8 hour post bypass | 84.070 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IP-10 24 hour post bypass | 241.467 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL 10 24 hour post bypass | 34.862 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-4 0 timepoint | 0.359 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | TNF alpha baseline | 5.402 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-15 2 hour post bypass | 4.641 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | TNF alpha 0 time point | 7.795 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-4 1 hour post bypass | 0.414 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | TNF alpha 1hour post bypass | 13.310 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | MIP-1 beta 2 hour post bypass | 40.900 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | TNF alpha 2 hour post bypass | 11.729 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-15 4 hour post bypass | 4.423 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | TNF alpha 4 hour post bypass | 9.291 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | MIP-1 beta 8 hour post bypass | 18.522 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | TNF alpha 6 hour post bypass | 7.953 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | MIP-1 alpha baseline | 0.000 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | TNF alpha 8 hour post bypass | 5.212 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | MIP-1 beta 24 hour post bypass | 16.082 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | TNF alpha 24 hour post bypass | 4.525 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-15 6 hour post bypass | 4.395 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | TNF beta 2 hour post bypass | 0.406 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | TNF beta baseline | 0.056 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | G-CSF baseline | 43.984 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | TNF beta 0 time point | 0.000 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-13 2 hour post bypass | 1.185 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | G-CSF 1 hour post bypass | 253.527 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | TNF beta 1 hour post bypass | 0.000 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-15 8 hour post bypass | 3.316 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | TNF beta 4 hour post bypass | 0.074 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | G-CSF 2 hour post bypass | 297.668 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | TNF beta 6 hour post bypass | 0.219 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | MIP-1 alpha 0 time point | 10.109 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | TNF beta 8 hour post bypass | 0.058 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | G-CSF 4 hour post bypass | 311.452 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | TNF beta 24 hour post bypass | 0.404 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-15 24 hour post bypass | 4.996 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | VEGF baseline | 44.971 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | G-CSF 6 hour post bypass | 224.425 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | VEGF 0 time point | 35.773 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | MIP-1 beta 4 hour post bypass | 24.018 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | VEGF 1 hour post bypass | 48.928 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | G-CSF 8 hour post bypass | 243.292 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | VEGF 4 hour poswt bypass | 30.529 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-17 baseline | 0.000 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | VEGF 6 hour post bypass | 26.226 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | G-CSF 24 hour post bypass | 199.849 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | VEGF 8 hour post bypass | 36.577 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL_4 2 hour post bypass | 1.381 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | VEGF 24 hour post bypass | 64.660 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | MIP-1 alpha 1 hour post bypass | 9.182 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | MCP-1 baseline | 182.708 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-4 4 hour post bypass | 0.958 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | MCP-1 0 timepoint | 455.129 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-17 0 time point | 0.117 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | MCP-1 1 hour post bypass | 572.955 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-4 6 hour post bypass | 0.746 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | MCP-1 2 hour post bypass | 502.992 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | MIP-1 beta baseline | 18.167 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | MCP-1 4 hour post bypass | 325.249 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-4 8 hour post bypass | 0.000 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | MCP-1 6 hour post bypass | 218.561 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-17 1 hour post bypass | 0.130 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | MCP-1 8 hour post bypass | 177.527 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL_4 24 hour post bypass | 0.000 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | MCP-1 24 hour post bypass | 215.708 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | MIP-1 alpha 2 hour post bypass | 6.268 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | EGF baseline | 39.794 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-5 baseline | 0.353 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | EGF 0 timepoint | 21.983 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-17 2 hour post bypass | 0.456 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | EGF 1 hour post bypass | 19.395 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-5 0 timepoint | 0.016 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | EGF 2 hour post bypass | 23.662 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-8 0 time point | 18.962 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | EGF 4 hour post bypass | 19.141 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-5 1 hour post bypass | 0.040 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | EGF 6 hour post bypass | 22.655 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-17 4 hour post bypass | 0.000 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | EGF 8 post bypass | 26.093 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-5 2 hour post bypass | 0.000 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | EGF 24 hour post bypass | 17.768 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | MIP-1 alpha 4 hour post bypass | 4.309 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1 alpha baseline | 2.754 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-5 4 hour post bypass | 0.016 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1 alpha 0 time | 31.597 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-17 6 hour post bypass | 0.162 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1 alpha 1 hour post bypass | 21.069 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-5 6 hour post bypass | 0.210 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1 alpha 2 hour post bypass | 17.803 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | VEGF 2 hour post bypass | 41.695 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1 alpha 4 hour post bypass | 10.732 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-5 8 hour post bypass | 0.431 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1 alpha 6 hour post bypass | 5.745 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL- 17 8 hour post bypass | 0.000 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1 alpha 8 hour post bypass | 5.376 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-5 24 hour post bypass | 0.503 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1 alpha 24 hour post bypass | 1.389 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | MIP-1 alpha 6 hour post bypass | 0.870 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1Beta baseline | 0.394 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-7 baseline | 2.987 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1Beta 0 time point | 0.492 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-17 24 hour post bypass | 0.0000 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1Beta 1 hour post bypass | 0.430 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-7 0 timepoint | 4.311 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1Beta 2 hour post bypass | 0.450 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | MIP-1 beta 6 hour post bypass | 20.263 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1Beta 4 hour post bypass | 0.310 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-7 1 hour post bypass | 1.822 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1Beta 6 hour post bypass | 0.366 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IP-10 baseline | 475.656 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1Beta 8 hour post bypass | 0.462 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-7 2 hour post bypass | 2.104 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1Beta 24 hour post bypass | 0.170 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | MIP-1 alpha 8 hour post bypass | 0.000 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1RA baseline | 0.000 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-7 4 hour post bypass | 2.530 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1RA 0 time point | 53.721 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IP-10 0 time point | 1790.035 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1RA 1 hour post bypass | 71.444 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-7 6 hour post bypass | 2.317 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1RA 2 hour post bypass | 237.080 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-13 0 timepoint | 0.000 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1RA 4 hour post bypass | 152.630 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-7 8 hour post bypass | 2.354 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1RA 6 hour post bypass | 75.226 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IP-10 1 hour post bypass | 2298.747 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1RA 8 hour post bypass | 27.442 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-7 24 hour post bypass | 4.097 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-1RA 24 hour post bypass | 15.765 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | MIP-1 alpha 24 hour post bypass | 0.000 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-2 baseline | 0.068 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-13 baseline | 0.000 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-2 0 timepoint | 0.401 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IP-10 2 hour post bypass | 1365.169 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-2 1 hour post bypass | 0.059 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | MIP-1 beta 0 time point | 47.617 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-2 2 hour post bypass | 1.110 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-13 4 hour post bypass | 0.287 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-2 4 hour post bypass | 0.870 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IP-10 4 hour post bypass | 855.843 pg/ml |
| Placebo | The Examine and Measure Cytokines to Measure Kidney Injury | IL-2 6 hour post bypass | 0.923 pg/ml |
The Examine and Measure Endothelin-1 to Measure Kidney Injury
Serial measurements of Endothelin-1 levels were measured to determine if natriuretic peptides exert their renal protective effects by preserving renal afferent arteriole flow by antagonizing the vasoconstrictive effects of Endothelin-1.
Time frame: 30 days from the start of infusion
Population: randomized as outlined in the protocol
| Arm | Measure | Group | Value (MEDIAN) |
|---|---|---|---|
| Nesiritide | The Examine and Measure Endothelin-1 to Measure Kidney Injury | baseline prior to infusion | 1.778 pg/ml |
| Nesiritide | The Examine and Measure Endothelin-1 to Measure Kidney Injury | time point 0 | 2.096 pg/ml |
| Nesiritide | The Examine and Measure Endothelin-1 to Measure Kidney Injury | 1 hour post bypass | 1.670 pg/ml |
| Nesiritide | The Examine and Measure Endothelin-1 to Measure Kidney Injury | 2 hour post bypass | 2.173 pg/ml |
| Nesiritide | The Examine and Measure Endothelin-1 to Measure Kidney Injury | 6 hour post bypass | 2.627 pg/ml |
| Nesiritide | The Examine and Measure Endothelin-1 to Measure Kidney Injury | 8 hour post bypass | 2.744 pg/ml |
| Nesiritide | The Examine and Measure Endothelin-1 to Measure Kidney Injury | 24 hour post bypass | 1.900 pg/ml |
| Nesiritide | The Examine and Measure Endothelin-1 to Measure Kidney Injury | 4 hour post bypass | 2.395 pg/ml |
| Placebo | The Examine and Measure Endothelin-1 to Measure Kidney Injury | 4 hour post bypass | 3.116 pg/ml |
| Placebo | The Examine and Measure Endothelin-1 to Measure Kidney Injury | baseline prior to infusion | 1.239 pg/ml |
| Placebo | The Examine and Measure Endothelin-1 to Measure Kidney Injury | 8 hour post bypass | 3.143 pg/ml |
| Placebo | The Examine and Measure Endothelin-1 to Measure Kidney Injury | time point 0 | 2.283 pg/ml |
| Placebo | The Examine and Measure Endothelin-1 to Measure Kidney Injury | 6 hour post bypass | 3.485 pg/ml |
| Placebo | The Examine and Measure Endothelin-1 to Measure Kidney Injury | 1 hour post bypass | 2.068 pg/ml |
| Placebo | The Examine and Measure Endothelin-1 to Measure Kidney Injury | 24 hour post bypass | 2.269 pg/ml |
| Placebo | The Examine and Measure Endothelin-1 to Measure Kidney Injury | 2 hour post bypass | 2.201 pg/ml |
The Examine and Measure Urinary NGAL to Measure Kidney Injury
Urinary NGAL,a biomarker for kidney injury was measured.
Time frame: A change in urinary NGAL 2 hours after bypass was stopped and 5 minutes after the start of spontaneous circulation was resumed.
Population: randomized as outlined in protocol
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| Nesiritide | The Examine and Measure Urinary NGAL to Measure Kidney Injury | 124.566 ng/ml |
| Placebo | The Examine and Measure Urinary NGAL to Measure Kidney Injury | 33.766 ng/ml |